Detalhe da pesquisa
1.
Neoadjuvant anthracycline-based (5-FEC) or anthracycline-free (docetaxel/carboplatin) chemotherapy plus trastuzumab and pertuzmab in HER2 + BC patients according to their TOP2A: a multicentre, open-label, non-randomized phase II trial.
Breast Cancer Res Treat
; 2024 Mar 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38453781
2.
Neoadjuvant chemotherapy with or without nintedanib for advanced epithelial ovarian cancer: Lessons from the GINECO double-blind randomized phase II CHIVA trial.
Gynecol Oncol
; 170: 186-194, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36706645
3.
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Lancet Oncol
; 22(5): 702-715, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33862000
4.
Spatial profiling of ovarian carcinoma and tumor microenvironment evolution under neoadjuvant chemotherapy.
Clin Cancer Res
; 2024 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38669064
5.
FOLFIRI Plus Durvalumab With or Without Tremelimumab in Second-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: The PRODIGE 59-FFCD 1707-DURIGAST Randomized Clinical Trial.
JAMA Oncol
; 2024 Apr 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-38573643
6.
Perioperative Cetuximab with Cisplatin and 5-Fluorouracil in Esogastric Adenocarcinoma: A Phase II Study.
Cancers (Basel)
; 15(7)2023 Apr 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37046849
7.
GINECO Prospective Non-interventional PROSPECTYON Study: Trabectedin Plus Pegylated Liposomal Doxorubicin for Platinum-sensitive Recurrent Ovarian Cancer.
Anticancer Res
; 40(7): 3939-3945, 2020 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-32620635
8.
CA-125 ELIMination Rate Constant K (KELIM) Is a Marker of Chemosensitivity in Patients with Ovarian Cancer: Results from the Phase II CHIVA Trial.
Clin Cancer Res
; 26(17): 4625-4632, 2020 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32209570
9.
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment.
Cell Death Dis
; 10(3): 199, 2019 02 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30814491
10.
Resection of small bowel adenocarcinoma metastases: Results of the ARCAD-NADEGE cohort study.
Eur J Surg Oncol
; 45(3): 331-335, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30501999
11.
Predicting everolimus treatment efficacy in patients with advanced endometrial carcinoma: a GINECO group study.
Target Oncol
; 8(4): 243-51, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-23238879